Sansure Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Sansure Biotech has a total shareholder equity of CN¥7.5B and total debt of CN¥399.4M, which brings its debt-to-equity ratio to 5.3%. Its total assets and total liabilities are CN¥8.7B and CN¥1.2B respectively. Sansure Biotech's EBIT is CN¥83.2M making its interest coverage ratio -0.3. It has cash and short-term investments of CN¥4.9B.
Key information
5.3%
Debt to equity ratio
CN¥399.36m
Debt
Interest coverage ratio | -0.3x |
Cash | CN¥4.95b |
Equity | CN¥7.53b |
Total liabilities | CN¥1.22b |
Total assets | CN¥8.75b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688289's short term assets (CN¥6.1B) exceed its short term liabilities (CN¥720.9M).
Long Term Liabilities: 688289's short term assets (CN¥6.1B) exceed its long term liabilities (CN¥495.6M).
Debt to Equity History and Analysis
Debt Level: 688289 has more cash than its total debt.
Reducing Debt: 688289's debt to equity ratio has increased from 0% to 5.3% over the past 5 years.
Debt Coverage: 688289's debt is not well covered by operating cash flow (9%).
Interest Coverage: 688289 earns more interest than it pays, so coverage of interest payments is not a concern.